184 related articles for article (PubMed ID: 25427922)
21. URG4 expression in invasive breast carcinoma and its relation to clinicopathological characteristics.
Aslan F; Avcıkurt AS
Breast Cancer; 2019 Jul; 26(4):485-491. PubMed ID: 30680688
[TBL] [Abstract][Full Text] [Related]
22. CISD2 expression is a novel marker correlating with pelvic lymph node metastasis and prognosis in patients with early-stage cervical cancer.
Liu L; Xia M; Wang J; Zhang W; Zhang Y; He M
Med Oncol; 2014 Sep; 31(9):183. PubMed ID: 25134919
[TBL] [Abstract][Full Text] [Related]
23. Elevated expression of iASPP correlates with poor prognosis and chemoresistance/radioresistance in FIGO Ib1-IIa squamous cell cervical cancer.
Cao L; Huang Q; He J; Lu J; Xiong Y
Cell Tissue Res; 2013 May; 352(2):361-9. PubMed ID: 23420450
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.
Zhou J; Liu X; Wang CH; Wang D; Du JJ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2997-3001. PubMed ID: 29863243
[TBL] [Abstract][Full Text] [Related]
26. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
[TBL] [Abstract][Full Text] [Related]
27. URG4 upregulation is associated with tumor growth and poor survival in epithelial ovarian cancer.
Li W; Zhou N
Arch Gynecol Obstet; 2012 Jul; 286(1):209-15. PubMed ID: 22395861
[TBL] [Abstract][Full Text] [Related]
28. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
Chen J; Zhu J
Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
[TBL] [Abstract][Full Text] [Related]
29. Fyn-related kinase expression predicts favorable prognosis in patients with cervical cancer and suppresses malignant progression by regulating migration and invasion.
Zhang X; Li F; Zhu PL
Biomed Pharmacother; 2016 Dec; 84():270-276. PubMed ID: 27665472
[TBL] [Abstract][Full Text] [Related]
30. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
31. URG4 expression is a novel prognostic factor for the progression of nasopharyngeal carcinoma and overall survival of patient.
Yu G; Meng Q; Zhang T; Zeng C; He B; Zhang S
Onco Targets Ther; 2016; 9():3059-65. PubMed ID: 27284257
[TBL] [Abstract][Full Text] [Related]
32. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
35. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
36. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
[TBL] [Abstract][Full Text] [Related]
37. Stomatin-like protein 2 expression is associated with clinical survival in patients with cervical cancer.
Xiao B; Xie Z; Guo L; Wu J; Zhang H
Int J Clin Exp Pathol; 2015; 8(2):1804-9. PubMed ID: 25973071
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics.
Yang M; Liu YD; Wang YY; Liu TB; Ge TT; Lou G
Tumour Biol; 2014 Feb; 35(2):929-34. PubMed ID: 23979981
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis.
Peng X; Wu Z; Yu L; Li J; Xu W; Chan HC; Zhang Y; Hu L
Gynecol Oncol; 2012 May; 125(2):470-6. PubMed ID: 22366595
[TBL] [Abstract][Full Text] [Related]
40. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]